The Mitochondrial Membrane Has a Maintenance Problem: What Phosphatidylcholine Reveals About Aging

Edited and Approved by Stephen C. Rose, PhD, MS

Mitochondria are often described as cellular power plants, but energy production is only part of their role. They also merge, divide, change shape, recycle damaged components, and communicate with the rest of the cell. Each of these functions depends on membranes that remain stable enough to protect the organelle and flexible enough to remodel when conditions change.

A 2026 Nature Communications study identifies a possible contributor to mitochondrial membrane decline: aging appears to reduce the synthesis of phosphatidylcholine, or PC, a major membrane lipid. In worms, the investigators disrupted PC production, observed fragmentation of mitochondrial networks and weaker respiration, and then supplied PC or its dietary precursor choline. Several defects improved, even when supplementation began late in life. Human datasets and cultured cells pointed in the same general direction, although the study did not test a treatment or biological-age outcome in people [1].

Why mitochondrial shape matters

Mitochondria form dynamic networks rather than remaining as isolated structures. Fusion allows them to combine membranes and contents, while fission helps distribute mitochondria and separate damaged sections. The appropriate balance depends on cell type, energy demand, and stress. In C. elegans, a laboratory roundworm widely used in aging research, increased mitochondrial fusion is required for several longevity pathways to support survival in old age. It is necessary in those models, but not sufficient by itself to produce longevity [2].

Membrane composition is part of this machinery. PC is abundant in mitochondrial membranes and helps determine their fluidity and curvature. Too little PC relative to neighboring lipids can make fusion more difficult and disturb proteins embedded in the membrane. Earlier worm experiments found that dietary PC extended lifespan, delayed movement decline, and activated the DAF-16 stress-response pathway, although it also reduced fertility and did not improve every form of stress resistance [3]. These results are valuable for identifying mechanisms, but they cannot be treated as human supplementation guidance.

How the investigators found the weak link

The new study began with ordinary wild-type worms and two long-lived strains, clk-1 and isp-1, whose mitochondria operate inefficiently from birth. Mild mitochondrial stress can activate compensatory programs that become protective, whereas more severe dysfunction remains harmful; dose, timing, and biological context are therefore important. The researchers measured 5,339 proteins in young, middle-aged, and old animals and asked which age-related changes occurred in normal worms but were reduced in both long-lived mutants [1].

Three proteins became central: SAMS-1, PMT-1, and PMT-2. Together they support a methylation-dependent route for making PC. All three fell sharply with advanced age in normal worms. When the researchers used RNA interference to suppress these genes in young animals, mitochondria lost their tubular networks, became fragmented, and consumed less oxygen. Lipid measurements confirmed a reduced ratio of PC to phosphatidylethanolamine. The sequence is more persuasive than a simple correlation: disable the pathway, change the lipid balance, damage the network, and impair respiration [1].

The findings also showed why the pathway cannot be reduced to a simple rule. Suppressing SAMS-1 or the PMT enzymes can lengthen life in otherwise normal young worms, yet the same intervention shortened life in the long-lived mitochondrial mutants. A pathway can therefore be beneficial in one metabolic state and harmful in another, underscoring the importance of genetic and physiological context [1].

The rescue experiment

The investigators next supplied PC or choline, which cells can use to make PC through a different route. Both interventions restored mitochondrial shape in genetically disrupted worms, and PC improved oxygen consumption. More important for aging, choline given during adulthood raised PC-related lipid ratios in older wild-type worms, reduced age-associated mitochondrial fragmentation, and improved late-life respiration. The intervention did not rebuild every youthful feature, but it partially repaired the exact defect predicted by the proposed mechanism [1].

This rescue is the study's most interesting result. Researchers did not merely notice that old animals contained less of a lipid. They perturbed the synthetic machinery, reproduced mitochondrial aging-like defects, and then bypassed the weak point nutritionally. That triangulation makes declining PC synthesis a plausible, malleable contributor to mitochondrial aging in this model. It does not make choline a human longevity therapy. The worm concentrations and exposure schedule are not a dosing guide, and lifespan was not the central outcome of the late-life rescue experiment [1].

What happened in human evidence

The human portion of the study was indirect. In GTEx tissue data, expression of PEMT, the human enzyme that performs a related PC-synthesis function, tended to decline with age in several organs. In UK Biobank blood data, PC-related metabolites also declined with age, most noticeably in postmenopausal women. These are population patterns, not experiments showing that reduced PC caused mitochondrial aging [1]. Tissue behavior may also differ: a study of human entorhinal cortex found relatively stable phospholipid composition across adulthood and an increased proportion of mitochondrial PC with age [4]. Results from one tissue or dataset should therefore not be generalized automatically to the entire body.

The researchers also stressed cultured human skin fibroblasts with high-dose metformin, which can inhibit mitochondrial complex I. Choline helped preserve cell survival and mitochondrial membrane potential, especially when combined with succinate, a fuel that can feed electrons through complex II. This supports conservation of the mechanism in human cells. It is still a laboratory stress model, not a study of choline supplementation in older adults, and certainly not evidence that people taking metformin should alter treatment [1].

Should people take more choline?

Choline is already an essential nutrient, not a newly discovered anti-aging molecule. Adults need it to make PC, acetylcholine, and methyl-group donors. Controlled feeding research shows that susceptibility to liver or muscle injury on a low-choline diet varies with genes involved in choline metabolism, including PEMT [5]. The National Institutes of Health lists adequate intakes of 550 milligrams per day for adult men and 425 milligrams for adult women, with different needs during pregnancy and lactation. Eggs, meat, fish, dairy foods, beans, cruciferous vegetables, nuts, seeds, and whole grains can contribute choline [6].

Meeting nutritional needs is not the same as taking high doses. The adult upper intake level is 3,500 milligrams per day, and excessive intake can cause low blood pressure, sweating, vomiting, fishy body odor, and liver toxicity [6]. Form also matters. In a randomized four-week human trial, choline bitartrate supplements increased trimethylamine N-oxide, or TMAO, and platelet responsiveness, while comparable choline supplied by eggs or phosphatidylcholine capsules did not [7]. That study did not establish that any form causes or prevents cardiovascular events, but it showed that source, dose, kidney function, and gut microbes can influence biological response.

Where the discovery leads

The most promising implication may not be a supplement bottle. PC synthesis could become a measurable vulnerability that helps explain why aging cells lose metabolic flexibility. Researchers can now ask whether maintaining PEMT activity, changing lipid transport, remodeling particular PC species, or targeting specific tissues preserves mitochondrial function in mammals. They will also need to determine when intervention helps, when it disrupts useful stress responses, and whether improvements in mitochondrial appearance translate into better organ function, healthspan, or lifespan.

The evidence supports a precise conclusion. In C. elegans, age-related decline in PC synthesis contributes causally to mitochondrial fragmentation and weaker respiration, and dietary PC or choline can partially rescue those defects. Human observational data and cell experiments make the mechanism plausible across species, but human rejuvenation remains untested. The discovery is important because it identifies a specific, experimentally modifiable pathway involved in mitochondrial aging. Determining whether that pathway can improve human healthspan will require controlled clinical research.

References

1. Poliezhaieva T, Li Y, Chaudhari PS, et al. Aging-associated decline of phosphatidylcholine synthesis is a malleable trigger of natural mitochondrial aging. Nat Commun. 2026;17(1):3589. doi:10.1038/s41467-026-71508-7.

2. Chaudhari SN, Kipreos ET. Increased mitochondrial fusion allows the survival of older animals in diverse C. elegans longevity pathways. Nat Commun. 2017;8(1):182. doi:10.1038/s41467-017-00274-4.

3. Kim SH, Kim BK, Park S, Park SK. Phosphatidylcholine Extends Lifespan via DAF-16 and Reduces Amyloid-Beta-Induced Toxicity in Caenorhabditis elegans. Oxid Med Cell Longev. 2019;2019:2860642. doi:10.1155/2019/2860642.

4. Hancock SE, Friedrich MG, Mitchell TW, Truscott RJW, Else PL. The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging. Geroscience. 2017;39(1):73-82. doi:10.1007/s11357-017-9961-2.

5. da Costa KA, Corbin KD, Niculescu MD, Galanko JA, Zeisel SH. Identification of new genetic polymorphisms that alter the dietary requirement for choline and vary in their distribution across ethnic and racial groups. FASEB J. 2014;28(7):2970-2978. doi:10.1096/fj.14-249557.

6. National Institutes of Health, Office of Dietary Supplements. Choline: Fact Sheet for Health Professionals. Accessed September 7, 2026.

7. Wilcox J, Skye SM, Graham B, et al. Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical Trial. Am J Med. 2021;134(9):1160-1169.e3. doi:10.1016/j.amjmed.2021.03.016.